Daniel Tasse

(Mr. Daniel Tasse)

Currently holds positions in DBV Technologies SA and Regenxbio Inc

Positions

Position Company Period
Chief Executive Officer, Director DBV Technologies SA March 5, 2019 -
Independent Director Regenxbio Inc Aug. 15, 2016 -
Director Bellerophon Therapeutics Inc Feb. 1, 2014 - May 14, 2019
Chief Executive Officer DBV Technologies SA Nov. 16, 2018 - March 5, 2019
Daniel Tasse's trades of DBV Technologies SA's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-11 2024-03-08
B Purchase
17,094 +inf%
0.83
USD 14,188 		17,094 +inf% 0.83 USD 14,188
2015-02-23 2015-02-19
B Purchase
25,000 +24.1%
12.00
USD 300,000 		25,000 +24.1% 12.00 USD 300,000
// ... existing code ... // ... rest of the file ...